Corticosteroids in the treatment of severe COVID-19 lung disease: The pulmonology perspective from the first united states epicenter

The SARS-CoV-2 pandemic has introduced the medical community to a lung disease heretofore unknown to most clinicians. In much of the discourse about COVID-19 lung disease, the more familiar clinical entity of ARDS has been used as the guiding paradigm. Reflecting on studies in ARDS, particularly tha...